Adoption of new technology in clinical trials, increasing chronic disease prevalence, and demand from developing countries are some of the major driving factors for the global marketplace. Whereas increasing demand for clinical trials by contract research organizations (CROs) is projected to further drive growth. Diversified experience of CROs in the success of clinical trials in a wide range of geographies and the production of drugs in different therapeutic areas compared to pharmaceutical companies are a few factors responsible for the demand for CROs in the pharmaceutical segment.
According to the BioOutsource Report 2017, the market for biosimilar testing is expected to see growth in the U.S., due to the fact that the Food and Drug Administration (FDA) has begun addressing the lack of clear guidelines about biosimilars, specifically the manner in which developers can demonstrate similarity between their drugs and the originator product. In January 2015, Hospira submitted one of Epogen's (Epoetin Alfa) biosimilar models, and the findings of the analysis in the U.S. are due from the FDA within one year.
The global clinical trials market is expected to grow owing to influential factors such as the rising demand for clinical trials due to the global expansion of the healthcare sectors, increasing expenditure towards research and development of the pharmaceutical industry, growing prevalence of chronic diseases, and the focus on the treatment methods for rare diseases.
For More Details Contact Us@ firstname.lastname@example.org
Clinical Trials in Healthcare Market Revenue & Forecast, (US$ Million), 2015 – 2027
Due to the presence of multiple major pharmaceutical companies, the increase in the patient population and the growing advances in product development, the Americas have been evaluated to dominate the global market for clinical trials. In addition, increasing cases of patients suffering from chronic diseases such as cancer, diabetes, and other life-threatening diseases increase demand for new medications, which lead to developing clinical trial approaches to improve treatment options. Those factors are also estimated to drive the region's market for clinical trials over the forecast period.
The key players identified in the global clinical market are: Charles River Laboratories, Clinipace, Eli Lilly and Company, ICON plc, Laboratory Corporation of America, Novo Nordisk A/S, Paraxel International Corporation, Pfizer, Quintiles IMS, SGS SA, among others.
Clinic Trails Healthcare Market:
By Phase: Phase I Trials, Phase II Trials, Phase III Trials
By Design: Interventional trials, Observational trials, Expanded Access trials
By Indication: Autoimmune Blood disorders, Cancer, Circulatory, CNS, Congenital, CVS, Dermatology, Ear, Gastrointestinal Genitourinary, Infections, Mental disorders, Metabolic, Musculoskeletal, Nose and Ophthalmology
North America: (U.S, Canada, Mexico, Rest of North America)
Europe: (France, The UK, Spain, Germany, Italy)
Nordic Countries: (Denmark, Finland, Iceland, Sweden, Norway)
Benelux Union: (Belgium, The Netherlands, Luxembourg, Rest of Europe)
Asia Pacific:(China, Japan, India, New Zealand, Australia, South Korea)
Southeast Asia: (Indonesia, Thailand, Singapore)
Rest of Southeast Asia
Middle East and Africa: (Saudi Arabia, UAE, Egypt, South Africa, Rest of Middle East and Africa)
Latin America: (Brazil, Argentina, Rest of Latina America)
For TOC and Reports Related Enquiry Mail Us@ email@example.com
GQ Market Reports is a company that is creating cutting edge, futuristic and informative reports in many different areas. Some of the most common areas where we generate reports are industry reports, country reports, company reports and everything in between. At Si market research, we give our clients the best reports that can be made in the market. Our reports are not only about market statistics, but they also contain a lot of information about new and niche company profiles.
+91 92843 95731